CAT and neoplasm: Compared with the LGT alone administration group, compatibility with JQC in the ratios (LGT/JQC from 4/1 to 1/4) all significantly reduced LGT-elevated MDA level (P<0.01) (Figure 3A), and elevated LGT-decreased GSH, GST, GPx, SOD, and CAT levels (all P<0.01) (Figure 3B–F) in hepatic of S180 tumor-bearing mice.